Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hyperhaploid plasma cell myeloma characterized by poor outcome and monosomy 17 with frequently co-occurring TP53 mutations.
Peterson JF, Rowsey RA, Marcou CA, Pearce KE, Williamson CM, Frederick LA, Greipp PT, Ketterling RP, Kumar S, Viswanatha DS, Polley MY, Fink JM, Reichard KK, Van Dyke DL, Baughn LB. Peterson JF, et al. Among authors: fink jm. Blood Cancer J. 2019 Feb 19;9(3):20. doi: 10.1038/s41408-019-0182-z. Blood Cancer J. 2019. PMID: 30783078 Free PMC article. No abstract available.
Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders.
Pugh TJ, Fink JM, Lu X, Mathew S, Murata-Collins J, Willem P, Fang M; Cancer Genomics Consortium Plasma Cell Disorders Working Group. Pugh TJ, et al. Among authors: fink jm. Cancer Genet. 2018 Dec;228-229:184-196. doi: 10.1016/j.cancergen.2018.07.002. Epub 2018 Oct 5. Cancer Genet. 2018. PMID: 30393007 Review.
Evidence-based review of genomic aberrations in diffuse large B cell lymphoma, not otherwise specified (DLBCL, NOS): Report from the cancer genomics consortium lymphoma working group.
Yenamandra AK, Smith RB, Senaratne TN, Kang SL, Fink JM, Corboy G, Hodge CA, Lu X, Mathew S, Crocker S, Fang M. Yenamandra AK, et al. Among authors: fink jm. Cancer Genet. 2022 Nov;268-269:1-21. doi: 10.1016/j.cancergen.2022.07.006. Epub 2022 Aug 4. Cancer Genet. 2022. PMID: 35970109 Review.
ERBB2 amplifications in esophageal adenocarcinoma.
Dahlberg PS, Jacobson BA, Dahal G, Fink JM, Kratzke RA, Maddaus MA, Ferrin LJ. Dahlberg PS, et al. Among authors: fink jm. Ann Thorac Surg. 2004 Nov;78(5):1790-800. doi: 10.1016/j.athoracsur.2004.05.037. Ann Thorac Surg. 2004. PMID: 15511476
65 results